MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$178,075K
(13.70%↑ Y/Y)
Trade receivables,
net
$146,229K
(100.13%↑ Y/Y)
Cash and cash
equivalents
$42,907K
(-39.85%↓ Y/Y)
Inventory
$22,634K
(55.82%↑ Y/Y)
Prepaid expenses and
other current assets
$21,079K
(7.24%↑ Y/Y)
Restricted cash
$308K
(-50.08%↓ Y/Y)
Total current assets
$411,232K
(22.46%↑ Y/Y)
Intangible assets, net
$14,812K
(56.26%↑ Y/Y)
Operating lease
right-of-use asset
$4,467K
(128.73%↑ Y/Y)
Other assets
$1,419K
(138.09%↑ Y/Y)
Property, plant, and
equipment, net
$1,043K
(0.19%↑ Y/Y)
Total assets
$432,973K
(24.10%↑ Y/Y)
Total liabilities and
stockholders equity
$432,973K
(24.10%↑ Y/Y)
Total liabilities
$243,494K
(27.25%↑ Y/Y)
Total stockholders
equity
$189,479K
(20.27%↑ Y/Y)
Accumulated deficit
-$1,138,084K
(-1.44%↓ Y/Y)
Accumulated other
comprehensive loss
-$44K
(-528.57%↓ Y/Y)
Total current
liabilities
$129,838K
(60.27%↑ Y/Y)
Long-term debt, net
$107,959K
(0.71%↑ Y/Y)
Operating lease
liability, long-term
$5,266K
(105.54%↑ Y/Y)
Other long-term
liabilities
$431K
(-24.39%↓ Y/Y)
Additional paid-in capital
$1,327,595K
(3.76%↑ Y/Y)
Common stock, 0.0001
par value...
$12K
(0.00%↑ Y/Y)
Accrued and other
current liabilities
$116,310K
(76.30%↑ Y/Y)
Accounts payable
$12,528K
(-11.90%↓ Y/Y)
Current portion of
long-term debt, net
$1,000K
Back
Back
Balance Sheet
source: myfinsight.com
logo-arcutis (1)-svg
Arcutis Biotherapeutics, Inc. (ARQT)
logo-arcutis (1)-svg
Arcutis Biotherapeutics, Inc. (ARQT)